Denosurel 120mg

DenosuRel is a specialized prescription biologic manufactured by Reliance Life Sciences containing Denosumab, a human monoclonal antibody. Supplied as a 120 mg single-use vial, this targeted therapy functions as a RANK ligand (RANKL) inhibitor. By binding to RANKL, it effectively prevents the activation of osteoclasts, the cells responsible for bone resorption. DenosuRel is primarily indicated under strict oncological supervision for preventing skeletal-related events in patients with advanced malignancies involving bone metastasis and for treating giant cell tumor of bone. It is designed solely for subcutaneous administration and requires careful clinical monitoring.